Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children
Authors:
- A.M.J. OduolaAOA.M.J. Oduola
- O.A.T. OgundahunsiOOO.A.T. Ogundahunsi
- C.O. FaladeCFC.O. Falade
- G.O. GbotoshoGGG.O. Gbotosho
- L.A. SalakoLSL.A. Salako
- 1 January 1997
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 91 (1) , 63-67
Abstract
Chlorpheniramine, a histamine H1 receptor antagonist, reverse chloroquine resistance in Plasmodium falciparum in vitro. However, the clinical significance of this remains unclear. We have evaluated the efficacy of chloroquine and a chloroquine-chlorpheniramine combination in 112 consecutive children with acute symptomatic uncomplicated falciparum malaria. There was no significant difference in the parasite and fever clearance times in the 2 treatment groups. However, the proportion of patients in whom parasitaemia increased 24 h after commencement of treatment was significantly higher in the chloroquine group than in the chloroquine-chlorpheniramine group (28.5% vs. 8.3%, chi 2 = 6.61, P < 0.01). There was also a higher proportion of children with RII and RIII responses to treatment in the chloroquine than in the chloroquine-chlorpheniramine group but the difference was not statistically significant. The cure rate on day 14 was higher in the chloroquine-chlorpheniramine group than in the chloroquine group. Chloroquine and its combination with chlorpheniramine were well tolerated, the only prominent adverse effect being pruritus, with equal incidence in both groups. Chlorpheniramine reversed chloroquine resistance in vitro in a similar manner to verapamil in isolates of P. falciparum obtained from the patients. Failure of a response in vivo to chloroquine correlated with resistance in vitro in patients treated with this drug. In contrast, all but one patient with isolates which were chloroquine resistant in vitro were successfully treated with chloroquine-chlorpheniramine combination. These data suggest the enhanced efficacy of chloroquine-chlorpheniramine combination in treating acute uncomplicated P. falciparum infection in children from an endemic area of Nigeria.Keywords
This publication has 15 references indexed in Scilit:
- Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 1994
- In Vitroandin VivoChloroquine-Potentiating Action ofStrychnos myrtoidesAlkaloids Against Chloroquine-Resistant Strains ofPlasmodiumMalariaPlanta Medica, 1994
- IN VITRO REVERSAL OF CHLOROQUINE RESISTANCE WITH CHLORPHENIRAMINE AGAINST AFRICAN ISOLATES OF PLASMODIUM FALCIPARUMJapanese Journal of Medical Science and Biology, 1994
- The potential of desipramine to reverse chloroquine resistance of Plasmodium falciparum is reduced by its binding to plasma proteinTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Reversal of Plasmodium falciparum Resistance to Chloroquine in Panamanian Aotus MonkeysThe American Journal of Tropical Medicine and Hygiene, 1993
- Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west NigeriaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Reversal of chloroquine resistance with cyproheptadine in ‘wild’ strains of Plasmodium falciparumTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- ANTIHISTAMINIC DRUGS THAT REVERSE CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUMThe Lancet, 1989
- Reversal of Chloroquine Resistance in Malaria Parasite Plasmodium falciparum by DesipramineScience, 1988
- Reversal of Chloroquine Resistance in Plasmodium falciparum by VerapamilScience, 1987